Use of the monoclonal antibody PAM4 to differentiate pancreatic ductal adenocarcinoma (PDAC) from chronic pancreatitis and benign nonmucinous cysts of the pancreas. Background: Somatostatin receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback